These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8013777)

  • 1. [Dysplasia and Barrett mucosa. Definition and significance].
    Diebold MD
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D24-8. PubMed ID: 8013777
    [No Abstract]   [Full Text] [Related]  

  • 2. Endoscopic resection of adenocarcinoma arising in a tongue of Barrett's esophagus.
    Harada M; Nagashima R; Takeda H; Takahashi T
    Gastrointest Endosc; 2000 Sep; 52(3):427-9. PubMed ID: 10968868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Barrett mucosa and mucosal secretion: does histochemistry of mucins have a predictive value?].
    Diebold MD
    Gastroenterol Clin Biol; 1994; 18(1 Pt 2):D29-30. PubMed ID: 8013778
    [No Abstract]   [Full Text] [Related]  

  • 4. [Barrett esophagus and Barrett carcinoma].
    Kruyt PH; van Sandick JW; van Lanschot JJ; Offerhaus GJ; Tytgat GN; Obertop H
    Ned Tijdschr Geneeskd; 1997 May; 141(18):869-73. PubMed ID: 9273450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Controversies of the cardiac mucosa and Barrett's oesophagus.
    Lombard C
    Histopathology; 2006 Jul; 49(1):97-8; author reply 98. PubMed ID: 16842257
    [No Abstract]   [Full Text] [Related]  

  • 6. The approach to high grade dysplasia in Barrett's esophagus.
    Case CL; Barkin JS
    Am J Gastroenterol; 2002 Jun; 97(6):1559-60. PubMed ID: 12094886
    [No Abstract]   [Full Text] [Related]  

  • 7. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
    Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
    Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duplication of the muscularis mucosae in Barrett esophagus: an underrecognized feature and its implication for staging of adenocarcinoma.
    Abraham SC; Krasinskas AM; Correa AM; Hofstetter WL; Ajani JA; Swisher SG; Wu TT
    Am J Surg Pathol; 2007 Nov; 31(11):1719-25. PubMed ID: 18059229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barrett's high-grade dysplasia: wait and watch?
    George SJ; Sharma P
    Am J Gastroenterol; 2002 Oct; 97(10):2674-5. PubMed ID: 12385460
    [No Abstract]   [Full Text] [Related]  

  • 10. Diagnosing and managing Barrett's esophagus.
    Sampliner RE
    Am J Manag Care; 2000 Oct; 6(16 Suppl):S886-90. PubMed ID: 11184660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Barrett esophagus: current state of the problem].
    Belova GV; Sokolov VV; Budzinskiĭ AA; Mel'chenko DS
    Eksp Klin Gastroenterol; 2007; (3):36-44. PubMed ID: 17937004
    [No Abstract]   [Full Text] [Related]  

  • 12. Esophageal adenocarcinoma.
    Wang KK
    Clin Gastroenterol Hepatol; 2006 Oct; 4(10):1221-4. PubMed ID: 16979951
    [No Abstract]   [Full Text] [Related]  

  • 13. High-grade dysplasia and superficial adenocarcinoma in Barrett's esophagus: histological mapping and expression of p53, p21 and Bcl-2 oncoproteins.
    Chatelain D; Fléjou JF
    Virchows Arch; 2003 Jan; 442(1):18-24. PubMed ID: 12536310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical diagnosis of adenocarcinoma of the esophago-gastric junction].
    Bîrla R; Iosif C; Gîndea C; Hoară P; Constantinoiu S
    Chirurgia (Bucur); 2007; 102(5):511-20. PubMed ID: 18018349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oesophageal adenocarcinoma.
    van Lanschot JJ
    Best Pract Res Clin Gastroenterol; 2006; 20(5):801-2. PubMed ID: 16997161
    [No Abstract]   [Full Text] [Related]  

  • 16. Gastroesophageal reflux disease, Barrett esophagus, and esophageal adenocarcinoma.
    Chang JT; Katzka DA
    Arch Intern Med; 2004 Jul; 164(14):1482-8. PubMed ID: 15277277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From Barrett esophagus to adenocarcinoma: can the dangers of natural history be overcome?].
    Robaszkiewicz M
    Gastroenterol Clin Biol; 1996; 20(5 Pt 2):B89-97. PubMed ID: 8761127
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical and endoscopic factors predict higher pathologic grades of Barrett dysplasia.
    Anandasabapathy S; Jhamb J; Davila M; Wei C; Morris J; Bresalier R
    Cancer; 2007 Feb; 109(4):668-74. PubMed ID: 17211862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extent of low-grade dysplasia is a risk factor for the development of esophageal adenocarcinoma in Barrett's esophagus.
    Srivastava A; Hornick JL; Li X; Blount PL; Sanchez CA; Cowan DS; Ayub K; Maley CC; Reid BJ; Odze RD
    Am J Gastroenterol; 2007 Mar; 102(3):483-93; quiz 694. PubMed ID: 17338734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-grade dysplasia in Barrett's esophagus - an innocent bystander? Contra.
    Vieth M
    Endoscopy; 2007 Jul; 39(7):647-9. PubMed ID: 17611921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.